JXR repurchases 3.23 million shares for HK$7.89 million; 54.46 million shares bought back under existing mandate

Bulletin Express
04/20

Jinxin Fertility Group Limited (JXR) disclosed a Next Day Disclosure Return dated 20 April 2026 detailing its latest share repurchase activity on the Hong Kong Stock Exchange.

• Latest transaction (20 April 2026): 3.23 million ordinary shares were bought back on-market at prices between HK$2.43 and HK$2.45 per share, for a total consideration of HK$7.89 million. All shares are designated for cancellation.

• Cumulative pending cancellation: Including the latest purchase, 14.80 million shares acquired between 27 March and 20 April 2026 remain to be cancelled.

• Share capital: Issued share capital stands at 2.71 billion shares. The repurchased shares have not yet been cancelled, so the issued share count is unchanged.

• Mandate utilisation: The current repurchase mandate, granted on 26 June 2025, authorises buybacks of up to 274.47 million shares. To date, JXR has repurchased 54.46 million shares, equal to 1.98 % of the company’s issued shares at the mandate’s adoption, leaving significant capacity for further purchases.

• Moratorium: In line with Hong Kong listing rules, JXR is restricted from issuing new shares until 20 May 2026, 30 days after the most recent repurchase.

The disclosure confirms that all repurchases complied with Hong Kong Stock Exchange regulations and the terms of the company’s explanatory statement dated 4 June 2025.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10